Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans
Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac53 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e3ed057f9f0f42f99db1388f0e83ac53 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e3ed057f9f0f42f99db1388f0e83ac532021-12-02T17:57:16ZConcomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans10.1038/s41598-021-94245-x2045-2322https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac532021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94245-xhttps://doaj.org/toc/2045-2322Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable lead isotope 204Pb as a tracer. In this randomized, placebo-controlled, double-blind, parallel-group study, 42 healthy participants were randomized to receive oral G-PUR 2.0 g, 2 * 2.0 g, or placebo, together with 2.5 µg of 204Pb in water. The enrichment of 204Pb caused by the tracer in blood and urine was measured by mass spectrometry. G-PUR was well tolerated. The mean maximum 204Pb enrichment of 0.505% of total blood lead was significantly higher (p < 0.0001) in the placebo group compared to G-PUR 2.0 g (0.073%) or G-PUR 2 * 2.0 g (0.057%) group. Normalized 204Pb AUC0-192 was 86.5, 11.9, and 8.5% * h without and with G-PUR 2.0 g, and G-PUR 2 * 2.0 g, respectively (p < 0.0001 vs. placebo). This smaller 204Pb exposure was paralleled by a reduced urinary excretion in subjects receiving G-PUR. Concomitant oral intake of purified clinoptilolite tuff reduced enteral uptake of 204Pb in healthy humans by approximately 90%. The reduced bioavailability is demonstrable by a decrease of 204Pb tracer enrichment in blood and urine. Trial registration: clinicaltrials.gov identifier: NCT04138693, registered 24/10/2019.Karolina SamekovaChrista FirbasJohanna IrrgeherChristine OpperThomas ProhaskaAnika RetzmannCornelius TscheggClaudia MeisslitzerAnastassiya TchaikovskyGhazaleh GouyaMichael FreissmuthMichael WolztNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Karolina Samekova Christa Firbas Johanna Irrgeher Christine Opper Thomas Prohaska Anika Retzmann Cornelius Tschegg Claudia Meisslitzer Anastassiya Tchaikovsky Ghazaleh Gouya Michael Freissmuth Michael Wolzt Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
description |
Abstract Lead exposure can cause substantial organ damage. Enteral lead absorption may be reduced by concomitant intake of clinoptilolite tuff, a zeolite from natural sources. This study aimed to assess the effect of purified clinoptilolite tuff (G-PUR) on enteral lead uptake in adults using stable lead isotope 204Pb as a tracer. In this randomized, placebo-controlled, double-blind, parallel-group study, 42 healthy participants were randomized to receive oral G-PUR 2.0 g, 2 * 2.0 g, or placebo, together with 2.5 µg of 204Pb in water. The enrichment of 204Pb caused by the tracer in blood and urine was measured by mass spectrometry. G-PUR was well tolerated. The mean maximum 204Pb enrichment of 0.505% of total blood lead was significantly higher (p < 0.0001) in the placebo group compared to G-PUR 2.0 g (0.073%) or G-PUR 2 * 2.0 g (0.057%) group. Normalized 204Pb AUC0-192 was 86.5, 11.9, and 8.5% * h without and with G-PUR 2.0 g, and G-PUR 2 * 2.0 g, respectively (p < 0.0001 vs. placebo). This smaller 204Pb exposure was paralleled by a reduced urinary excretion in subjects receiving G-PUR. Concomitant oral intake of purified clinoptilolite tuff reduced enteral uptake of 204Pb in healthy humans by approximately 90%. The reduced bioavailability is demonstrable by a decrease of 204Pb tracer enrichment in blood and urine. Trial registration: clinicaltrials.gov identifier: NCT04138693, registered 24/10/2019. |
format |
article |
author |
Karolina Samekova Christa Firbas Johanna Irrgeher Christine Opper Thomas Prohaska Anika Retzmann Cornelius Tschegg Claudia Meisslitzer Anastassiya Tchaikovsky Ghazaleh Gouya Michael Freissmuth Michael Wolzt |
author_facet |
Karolina Samekova Christa Firbas Johanna Irrgeher Christine Opper Thomas Prohaska Anika Retzmann Cornelius Tschegg Claudia Meisslitzer Anastassiya Tchaikovsky Ghazaleh Gouya Michael Freissmuth Michael Wolzt |
author_sort |
Karolina Samekova |
title |
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
title_short |
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
title_full |
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
title_fullStr |
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
title_full_unstemmed |
Concomitant oral intake of purified clinoptilolite tuff (G-PUR) reduces enteral lead uptake in healthy humans |
title_sort |
concomitant oral intake of purified clinoptilolite tuff (g-pur) reduces enteral lead uptake in healthy humans |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/e3ed057f9f0f42f99db1388f0e83ac53 |
work_keys_str_mv |
AT karolinasamekova concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT christafirbas concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT johannairrgeher concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT christineopper concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT thomasprohaska concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT anikaretzmann concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT corneliustschegg concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT claudiameisslitzer concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT anastassiyatchaikovsky concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT ghazalehgouya concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT michaelfreissmuth concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans AT michaelwolzt concomitantoralintakeofpurifiedclinoptilolitetuffgpurreducesenteralleaduptakeinhealthyhumans |
_version_ |
1718379080821243904 |